Literature DB >> 1942426

Astemizole-induced cardiac conduction disturbances in a child.

J R Tobin1, T P Doyle, A D Ackerman, J I Brenner.   

Abstract

The newly available antihistamine astemizole (Hismanal) has been previously associated with hemodynamically significant cardiac tachydysrhythmias. We describe a 3-year-old girl who developed multiple different cardiac dysrhythmias after an astemizole overdose. No hemodynamic compromise occurred, and the electrocardiogram returned to normal without use of antiarrhythmic agents within 7 hours.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1942426

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  12 in total

Review 1.  Cardiotoxicity of histamine and the possible role of histamine in the arrhythmogenesis produced by certain antihistamines.

Authors:  J Llenas; I Cardelús; A Heredia; F de Mora; R W Gristwood
Journal:  Drug Saf       Date:  1999       Impact factor: 5.606

Review 2.  Cytochrome P450 3A: ontogeny and drug disposition.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

3.  Antihistamines and the heart.

Authors:  D Marquardt
Journal:  West J Med       Date:  1993-06

Review 4.  Comparative tolerability of second generation antihistamines.

Authors:  F Horak; U P Stübner
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

5.  Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.

Authors:  Hanna Phan; Matthew L Moeller; Milap C Nahata
Journal:  Drugs       Date:  2009       Impact factor: 9.546

6.  Public health problems and the rapid estimation of the size of the population at risk. Torsades de pointes and the use of terfenadine and astemizole in The Netherlands.

Authors:  R M Herings; B H Stricker; H G Leufkens; A Bakker; F Sturmans; J Urquhart
Journal:  Pharm World Sci       Date:  1993-10-15

Review 7.  Macrolide antibacterials. Drug interactions of clinical significance.

Authors:  N A von Rosensteil; D Adam
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

8.  Possible interactions with terfenadine or astemizole.

Authors:  A D Zechnich; J R Hedges; D Eiselt-Proteau; D Haxby
Journal:  West J Med       Date:  1994-04

Review 9.  H1-receptor antagonists. Comparative tolerability and safety.

Authors:  F E Simons
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 10.  Safety and tolerability of treatments for allergic rhinitis in children.

Authors:  Carlos E Baena-Cagnani
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.